Ángelo Torres
Impact in
- Physiology top 2%
- Adenosine and Purinergic Signaling
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Physiology 12
- Adenosine and Purinergic Signaling 12
- Genetics 8
- Glioma Diagnosis and Treatment 8
- Genetic and Kidney Cyst Diseases 1
- Co-authors
- Claudia Quezada (14 shared papers)Rody San Martín (15 shared papers)Daniel Uribe (9 shared papers)Ignacio Niechi (9 shared papers)Carlos Oyarzún (10 shared papers)José Ignacio Erices (7 shared papers)Luis Sobrevía (2 shared papers)Claudia Jara (6 shared papers)
In The Last Decade
Ángelo Torres
20 papers receiving 605 citations
Peers
Comparison fields: 5 of 78
- Physiology 131
- Genetics 149
- Cancer Research 153
- Nephrology 35
- Molecular Biology 315
Countries citing papers authored by Ángelo Torres
This map shows the geographic impact of Ángelo Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángelo Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángelo Torres more than expected).
Fields of papers citing papers by Ángelo Torres
This network shows the impact of papers produced by Ángelo Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángelo Torres. The network helps show where Ángelo Torres may publish in the future.
Co-authors
The 25 scholars most cited alongside Ángelo Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 100 | |
| 2 | 2017 | 63 | |
| 3 | 2019 | 60 | |
| 4 | 2023 | 57 | |
| 5 | 2016 | 49 | |
| 6 | 2020 | 43 | |
| 7 | 2016 | 38 | |
| 8 | 2018 | 38 | |
| 9 | 2018 | 36 | |
| 10 | 2019 | 24 | |
| 11 | 2020 | 20 | |
| 12 | 2019 | 17 | |
| 13 | 2019 | 16 | |
| 14 | 2020 | 15 | |
| 15 | 2018 | 12 | |
| 16 | 2023 | 8 | |
| 17 | 2023 | 6 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 1 |
About Ángelo Torres
Ángelo Torres is a scholar working on Physiology, Genetics, Molecular Biology, Cancer Research and Nephrology, having authored 21 papers that have together received 609 indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (12 papers), Glioma Diagnosis and Treatment (8 papers), MicroRNA in disease regulation (3 papers), Chronic Kidney Disease and Diabetes (3 papers), Renal Diseases and Glomerulopathies (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Genetic and Kidney Cyst Diseases (1 paper). The work is most often cited by research in Physiology (131 citations), Genetics (149 citations), Cancer Research (153 citations), Nephrology (35 citations) and Molecular Biology (315 citations). Ángelo Torres has collaborated with scholars based in Chile, Spain and Australia. Frequent co-authors include Claudia Quezada, Rody San Martín, Daniel Uribe, Ignacio Niechi, Carlos Oyarzún, José Ignacio Erices, Luis Sobrevía, Claudia Jara, Flavio Salazar‐Onfray and Pamela Ehrenfeld. Their work appears in journals such as Cells, International Journal of Molecular Sciences, Molecular Aspects of Medicine, Journal of Feline Medicine and Surgery and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.